News Releases Archives - Page 2 of 2 - Asia Green Biotechnology Corp

Medical Cannabis is Gaining Momentum in Asia

Many Asian countries are softening their tone on cannabis, but the plant remains illegal in the majority of Asian nations.Consultancy Prohibition Partners estimates that Asia’s medicinal cannabis market could by 2024 be worth $5.8 billion. As for investing opportunities, many are still reluctant to…

Asia Cannabis Corp. Announces Completion of Initial Public Offering

Calgary, Alberta--(Newsfile Corp. - January 11, 2019) - Asia Cannabis Corp. (CSE: ASIA) ("Asia" or the "Corporation") is pleased to announce that it has completed its initial public offering of 5,047,000 common shares at the price of $0.25 per common share pursuant…

LATEST NEWS

Asia Green Biotechnology Corp. Announces Passing of Johannes Kingma Asia Green Biotechnology Director: Bringing Canadian Cannabis Expertise to Asia (Investing News Network Interview) Asia Green Biotechnology Corp. And Inplanta Biotechnology Ltd. Announce Grant Of Full Registration Of “Bountiful” Hemp Cultivar Asia Green Biotechnology Corp. Enters Memorandum Of Agreement With Agricultural College In Cambodia To Evaluate Hemp Production Potential CTV: Medicinal cannabis mouthwash could help combat COVID-19 Asia Green Biotechnology Corp. Expands Technology License Agreement with Pathway Rx Inc. by Entering Corresponding Agreement with PNW Biosciences Inc. Forbes: ‘Cannabis Treats COVID-19’ Rallied Weed Stocks: Cannabis Could Aid Pandemic—If Someone Pays To Find Out Asia Green Biotechnology Corp. Enters Technology License Agreement with Pathway Rx Inc. for Asia Region and Agrees to Assist in Initiating Clinical Trials Covid-19 & Cannabis Research The GrowthOp: This Alberta scientist received worldwide attention for his cannabis and COVID-19 study. But getting funding and a clinical trial going in Canada remains a massive challenge